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ABSTRACT 
A decoction of the roots of Prismatomeris glabra (PG), family Rubiaceae, has been 
traditionally used by rural people for wellness, improvement of stamina and for 
aphrodisiac effects. However there were no scientific data to support the folkloric use of 
this plant. This research was thus conducted to determine whether aqueous extract of P. 
glabra roots possess antioxidant capacity, produce ergogenic effects and improve sexual 
function. Toxicity studies were performed to estimate safety for human consumption. PG 
extract was prepared by boiling powdered roots for 10 minutes before drying in spray 
dryer. Toxicity studies in mice were conducted for acute, subacute and subchronic effects. 
OECD guidelines were used for 14-day observation following acute dose given to male 
and female mice intraperitoneally. In all experiments, age-matched control mice were 
given normal salkie. Gross necropsy, hematology and biochemistry analyses were 
conducted following killing. Toxicity studies in vitro were conducted using selected cell 
lines. Antioxidant capacity was determined in vitro and in vivo using established methods. 
Ergogenic effects were studied in weight-bearing mice performing forced swim test 
(FST) to exhaustion following treatment with 500 mg/kg/d p.o. PG. Mice were killed 
immediately after the final FST for blood biomarker assays. Castrated/non-castrated mice 
were used to determine the effect of PG (500 mg/kg/d p.o.) on testosterone levels. Males 
were introduced to sexually receptive female for mounts and intromissions activities 
assessment. In vitro, cultured Leydig cells (CRL1714) were treated with PG for 
testosterone production. Results show PG to be safe. Mice were able to tolerate PG to a 
maximum single dose of 3 g/kg, p.o., 500 mg/kg/d, p.o., daily for 14 days, and at 100 
mg/kg/d, p.o., daily for 3 months, respectively, without showing signs of toxicity or 
abnormal biochemical markers and hematology. PG also showed no genotoxic and 
cytotoxic effects. Results also show PG is a potent antioxidant when phenolic content, 
lipid- and water-soluble antioxidant capacities of PG were 6.82±0.71%, 36.61±1.39 
(ig/mg of ascorbic acid equivalent and 8.28±1.23 |ig/mg of trolox equivalent, 
respectively. PG scavenged DPPH radicals, reduced ferric ions and inhibited tert-BOOH-
induced lipid peroxidation with values of 239.31±70.48 ng/ml (EC50), 0.298 ± 0.026 
|nmol Fe +/mg and 188.7±15.3 (IC50), respectively. PG also did not affect 
malondialdehyde levels of major organs and plasma. In ergogenic studies, mice treated 
with PG showed greater exercise performance than control (p=0.000) or L-arginine 
(p=0.001) groups. Post-exercise blood glucose levels of PG-treated mice was greater than 
those of control exercised (p=O.011) but similar to control non-exercised and L-arginine 
groups. PG did not influence blood lactate and serum corticosterone following exercise. 
Testosterone and corticosterone were also not influenced by administration of PG. Mice 
treated with PG showed greater frequency of mounting than control in 1st (p=0.021) and 
2nd (p=0.032) sexual meeting. PG-treated mice also showed greater intromission duration 
(p=0.01) and frequency (p=0.02) than control in 3rd meeting. PG also had no effect on 
luteinizing hormone. In conclusion, based on toxicity data, PG root aqueous extract is 
generally safe for consumption. PG roots may not be an important source of antioxidants 
although it apparently has sufficient antioxidant capacity to enhance wellness. Findings of 
this study provide evidence to confirm the traditional use of PG roots to increase stamina; 
improve physical performance and as aphrodisiac. 
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